Moderna MRNA reported its Q2 earnings results on Wednesday, August 3, 2022.
Here's what investors need to know about the announcement.
Earnings
Moderna beat estimated earnings by 14.16%, reporting an EPS of $5.24 versus an estimate of $4.59.
Revenue was up $395.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $3.37 which was followed by a 8.4% drop in the share price the next day.
Here's a look at Moderna's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 5.21 | 9.90 | 9.09 | 6.04 |
EPS Actual | 8.58 | 11.29 | 7.70 | 6.46 |
Revenue Estimate | 4.43B | 6.79B | 6.23B | 4.28B |
Revenue Actual | 6.07B | 7.21B | 4.97B | 4.35B |
To track all earnings releases for Moderna visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.